ATAVISTIC CHEMOTHERAPY & IMMUNOTHERAPY

Atavistic Chemotherapy and Immunotherapy

Contrary to popular belief, chemotherapy does not refer only to the use of toxic drugs to treat cancer. By definition, chemotherapy is simply a therapy based on the use of chemicals (drugs). In the case of depression, for example, a psychiatrist may opt to treat a patient with chemotherapy (chemical medications), instead of using psychotherapy or electro-convulsive therapy. In reality, a practice as common as taking vitamins to prevent or treat a disease is chemotherapy, because vitamins are chemicals (drugs), as are Tylenol® (acetaminophen), Advil® (Ibuprofen), etc.

Immunotherapy is defined as a treatment whose goal is to modify the immune system to achieve health. As is the case with chemotherapy, the use of immunotherapy is not limited to cancer treatment; many other diseases can be treated in this fashion.

Atavism is a state in which a cell, or even an entire organism, expresses genetic traits that were commonly seen in its evolutionary ancestors. These are structural and visible traits which have not normally been seen for a very long time, but which inexplicably make a reappearance.

Atavistic Chemotherapy implies the selection and use of drugs (chemicals) that, based on the principles of Atavistic Oncology, should be effective in killing cells which have deevolved or returned to a primitive unicellular behavior (malignant behavior). These are drugs which have historically been used in the treatment of diseases in which primitive cells proliferate, invade and metastasize (migrate). These diseases include bacterial, protozoal and fungal infections. Atavistic Immunotherapy is the use of vaccines to stimulate the immune system, encouraging it to attack unicellular organisms or their toxic by-products.

 

Why a Therapy Directed Against Bacteria, Protozoa and Fungus?

As indicated in the introductory video and other sections of our website (www.AtavisticChemotherapy.com), along with plants and other animals, human beings are multicellular organisms. This means that our bodies are formed by groups of cells with different abilities and functions. Despite the apparently great differences between types of cells in our bodies, all multicellular organisms evolved from bacteria-like unicellular organisms over a period of several billion years. In fact, most of our cellular functions are biologically identical to the functions of unicellular organisms like bacteria, protozoa and fungi. Among these identical functions are the metabolism of glucose, DNA replication, and the synthesis of enzymes and other proteins.

Atavistic oncology postulates that cancer cells are cells that have reactivated past evolutionary genetic information preserved in the genome (DNA). Thus cancer cells reacquire the abilities and behavior of their ancestral precursor cells, the primitive unicellular organisms. Therefore, malignant or pathogenic characteristics found in cancer cells such as unlimited replicative potential; capacity for invasion, migration, and metastases; ability to evade the host’s immune system, and acquire multidrug resistance; and ability to live in hostile conditions are cellular traits reasserted from their hereditary past as primitive, independent single-celled organisms.

This does not imply that cancer cells are bacteria, or protozoa, or yeasts. It means that cancer cells express functions or behaviors similar to their ancestral parents, the unicellular organisms (such as bacteria-like and protist-like organisms) from which our cells originated.

If this is true, a combination of drugs that are effective to eradicate certain unicellular organisms should work in cancer treatment. Not only should they work, but this approach must also be superior to any other approach used in the past to treat cancer. Because of the overwhelming results we have obtained and shown on our website, we prophesize that Atavistic Chemotherapy and Immunotherapy will become the way cancer is treated in the world. 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Atavistic Chemotherapy and Immunotherapy

Contrary to popular belief, chemotherapy does not refer only to the use of toxic drugs to treat cancer. By definition, chemotherapy is simply a therapy based on the use of chemicals (drugs). In the case of depression, for example, a psychiatrist may opt to treat a patient with chemotherapy (chemical medications), instead of using psychotherapy or electro-convulsive therapy. In reality, a practice as common as taking vitamins to prevent or treat a disease is chemotherapy, because vitamins are chemicals (drugs), as are Tylenol® (acetaminophen), Advil® (Ibuprofen), etc.

Immunotherapy is defined as a treatment whose goal is to modify the immune system to achieve health. As is the case with chemotherapy, the use of immunotherapy is not limited to cancer treatment; many other diseases can be treated in this fashion.

Atavism is a state in which a cell, or even an entire organism, expresses genetic traits that were commonly seen in its evolutionary ancestors. These are structural and visible traits which have not normally been seen for a very long time, but which inexplicably make a reappearance.

Atavistic Chemotherapy implies the selection and use of drugs (chemicals) that, based on the principles of Atavistic Oncology, should be effective in killing cells which have deevolved or returned to a primitive unicellular behavior (malignant behavior). These are drugs which have historically been used in the treatment of diseases in which primitive cells proliferate, invade and metastasize (migrate). These diseases include bacterial, protozoal and fungal infections. Atavistic Immunotherapy is the use of vaccines to stimulate the immune system, encouraging it to attack unicellular organisms or their toxic by-products.

 

Why a Therapy Directed Against Bacteria, Protozoa and Fungus?

As indicated in the introductory video and other sections of our website (www.AtavisticChemotherapy.com), along with plants and other animals, human beings are multicellular organisms. This means that our bodies are formed by groups of cells with different abilities and functions. Despite the apparently great differences between types of cells in our bodies, all multicellular organisms evolved from bacteria-like unicellular organisms over a period of several billion years. In fact, most of our cellular functions are biologically identical to the functions of unicellular organisms like bacteria, protozoa and fungi. Among these identical functions are the metabolism of glucose, DNA replication, and the synthesis of enzymes and other proteins.

Atavistic oncology postulates that cancer cells are cells that have reactivated past evolutionary genetic information preserved in the genome (DNA). Thus cancer cells reacquire the abilities and behavior of their ancestral precursor cells, the primitive unicellular organisms. Therefore, malignant or pathogenic characteristics found in cancer cells such as unlimited replicative potential; capacity for invasion, migration, and metastases; ability to evade the host’s immune system, and acquire multidrug resistance; and ability to live in hostile conditions are cellular traits reasserted from their hereditary past as primitive, independent single-celled organisms.

This does not imply that cancer cells are bacteria, or protozoa, or yeasts. It means that cancer cells express functions or behaviors similar to their ancestral parents, the unicellular organisms (such as bacteria-like and protist-like organisms) from which our cells originated.

If this is true, a combination of drugs that are effective to eradicate certain unicellular organisms should work in cancer treatment. Not only should they work, but this approach must also be superior to any other approach used in the past to treat cancer. Because of the overwhelming results we have obtained and shown on our website, we prophesize that Atavistic Chemotherapy and Immunotherapy will become the way cancer is treated in the world. 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

View Comment( 4 )

Susan M Thu, Apr 17,2014 01:59 AM
Fantastic! Thank you Dr. Arguello
Rob Anderson Tue, May 06,2014 05:00 AM
Very informative.
Kasual1234 Fri, Sep 26,2014 01:44 PM
I find this website incredibly interesting and exciting that someone is thinking out of the box to find new ways of dealing with Cancel. This should be headline news not something that one just happens upon. I disagree with the authors evaluation of alternative medicine. It is unfairly evaluated if you consider that most getting alternative cancer treatment do so AFTER using conventional and are in advanced stages and compromised immune systems and have been giving up by conventional medicine and still there are many successe using it. Many are still turing their ill health completely around using alternative methods. Thank you for going the extra mile and daring to break away from conventional thinking.
Dr. Diego Theumann (Ph.D. organic chemistry,73 y. old) Wed, Aug 05,2015 04:49 PM
Is there any experience in treating multiple myeloma with atavistic chemotherapy ? I have already had for cycles of conventional chemotherapy (Bortezomib,Dexamethasone,Lenalidomide and Zoledronic acid) to treat my MM and the results seem to be promising. But my peripheral neuropathy (legs and feet) has become worse due to some of the chemicals used to treat the MM. Hope to hear from you ! Best regards. Diego.
Leave a Comment